These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 26253281)
1. Risk Factors for Occult Uterine Sarcoma Among Women Undergoing Minimally Invasive Gynecologic Surgery. Oduyebo T; Hinchcliff E; Meserve EE; Seidman MA; Quade BJ; Rauh-Hain JA; George S; Nucci MR; del Carmen MG; Muto MG J Minim Invasive Gynecol; 2016 Jan; 23(1):34-9. PubMed ID: 26253281 [TBL] [Abstract][Full Text] [Related]
2. Retrospective cohort study evaluating the impact of intraperitoneal morcellation on outcomes of localized uterine leiomyosarcoma. George S; Barysauskas C; Serrano C; Oduyebo T; Rauh-Hain JA; Del Carmen MG; Demetri GD; Muto MG Cancer; 2014 Oct; 120(20):3154-8. PubMed ID: 24923260 [TBL] [Abstract][Full Text] [Related]
3. Risk of morcellation of uterine leiomyosarcomas in laparoscopic supracervical hysterectomy and laparoscopic myomectomy, a retrospective trial including 4791 women. Lieng M; Berner E; Busund B J Minim Invasive Gynecol; 2015; 22(3):410-4. PubMed ID: 25460521 [TBL] [Abstract][Full Text] [Related]
4. Characterization and Preoperative Risk Analysis of Leiomyosarcomas at a High-Volume Tertiary Care Center. Peters A; Sadecky AM; Winger DG; Guido RS; Lee TTM; Mansuria SM; Donnellan NM Int J Gynecol Cancer; 2017 Jul; 27(6):1183-1190. PubMed ID: 28463949 [TBL] [Abstract][Full Text] [Related]
5. Incidence of Malignancy and Myoma Variants at Surgery for Presumed Benign Symptomatic Myomas. Damasco MR; Chan PK; Slonim M; Ang WC; Healey MG J Minim Invasive Gynecol; 2017; 24(4):659-664. PubMed ID: 28216458 [TBL] [Abstract][Full Text] [Related]
6. Unexpected Uterine Leiomyosarcoma During Laparoscopic Hysterectomy Treated 6 Months With Ulipristal Acetate and Contained Power Morcellation. Istre O J Minim Invasive Gynecol; 2017 Feb; 24(2):198. PubMed ID: 27539216 [TBL] [Abstract][Full Text] [Related]
7. A Multicentre Retrospective Review of Clinical Characteristics of Uterine Sarcoma. Wais M; Tepperman E; Bernardini MQ; Gien LT; Jimenez W; Murji A J Obstet Gynaecol Can; 2017 Aug; 39(8):652-658. PubMed ID: 28729098 [TBL] [Abstract][Full Text] [Related]
8. Occult Leiomyosarcomas in a Canadian Province: A Retrospective Cohort Study. Wu CQ; Woo LY; Giede KC; Thiel J; Karreman E; Rattray DD J Obstet Gynaecol Can; 2019 Jan; 41(1):46-51. PubMed ID: 30341020 [TBL] [Abstract][Full Text] [Related]
9. The value of re-exploration in patients with inadvertently morcellated uterine sarcoma. Oduyebo T; Rauh-Hain AJ; Meserve EE; Seidman MA; Hinchcliff E; George S; Quade B; Nucci MR; Del Carmen MG; Muto MG Gynecol Oncol; 2014 Feb; 132(2):360-5. PubMed ID: 24296345 [TBL] [Abstract][Full Text] [Related]
11. Clinical Characteristics and Prognosis of Unexpected Uterine Sarcoma After Hysterectomy for Presumed Myoma With and Without Transvaginal Scalpel Morcellation. Zhang J; Li T; Zhang J; Zhu L; Lang J; Leng J Int J Gynecol Cancer; 2016 Mar; 26(3):456-63. PubMed ID: 26807642 [TBL] [Abstract][Full Text] [Related]
12. Occult uterine leiomyosarcoma in women undergoing abdominal and minimally invasive surgeries for myomas. Ludwin A; Gawron I; Pityński K Ginekol Pol; 2018; 89(10):546-552. PubMed ID: 30393842 [TBL] [Abstract][Full Text] [Related]
13. Assessing the risk of laparoscopic morcellation of occult uterine sarcomas during hysterectomy and myomectomy: Literature review and the ISGE recommendations. Sizzi O; Manganaro L; Rossetti A; Saldari M; Florio G; Loddo A; Zurawin R; van Herendael B; Djokovic D Eur J Obstet Gynecol Reprod Biol; 2018 Jan; 220():30-38. PubMed ID: 29149644 [TBL] [Abstract][Full Text] [Related]
14. Uterine Sarcomas in Patients Undergoing Surgery for Presumed Leiomyomas: 10 Years' Experience. Paul PG; Rengaraj V; Das T; Garg R; Thomas M; Khurd AS J Minim Invasive Gynecol; 2016; 23(3):384-9. PubMed ID: 26677821 [TBL] [Abstract][Full Text] [Related]
15. Feasibility, Safety, and Prediction of Complications for Minimally Invasive Myomectomy in Women With Large and Numerous Myomata. Vargas MV; Moawad GN; Sievers C; Opoku-Anane J; Marfori CQ; Tyan P; Robinson JK J Minim Invasive Gynecol; 2017 Feb; 24(2):315-322. PubMed ID: 27939896 [TBL] [Abstract][Full Text] [Related]
17. Electric morcellation-related reoperations after laparoscopic myomectomy and nonmyomectomy procedures. Pereira N; Buchanan TR; Wishall KM; Kim SH; Grias I; Richard SD; Della Badia CR J Minim Invasive Gynecol; 2015 Feb; 22(2):163-76. PubMed ID: 25218993 [TBL] [Abstract][Full Text] [Related]
18. The effect of a gynecologist-interventional radiologist relationship on selection of treatment modality for the patient with uterine myoma. Zurawin RK; Fischer JH; Amir L J Minim Invasive Gynecol; 2010; 17(2):214-21. PubMed ID: 20226411 [TBL] [Abstract][Full Text] [Related]
19. Incidence of Tissue Morcellation During Surgery for Uterine Sarcoma at a Canadian Academic Centre. Chen I; Hopkins L; Firth B; Boucher J; Singh SS J Obstet Gynaecol Can; 2015 May; 37(5):421-425. PubMed ID: 26168102 [TBL] [Abstract][Full Text] [Related]
20. The impact of tumor morcellation during surgery on the prognosis of patients with apparently early uterine leiomyosarcoma. Park JY; Park SK; Kim DY; Kim JH; Kim YM; Kim YT; Nam JH Gynecol Oncol; 2011 Aug; 122(2):255-9. PubMed ID: 21565389 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]